We are live on ! Find out more
BVS icon

Bioventus
BVS

53 hedge funds and large institutions have $364M invested in Bioventus in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

50.48% more ownership

Funds ownership: 0% → 50.48% (+50%)

18% more funds holding

Funds holding: 45 → 53 (+8)

9% more capital invested

Capital invested by funds: $334M → $364M (+$30.3M)

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
53
Holders Change
+8
Holders Change %
+17.78%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
15
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NI
Nuance Investments
Missouri
+$11.2M
2
UBS AM
UBS AM
Illinois
+$6.44M
3
JP Morgan Chase
JP Morgan Chase
New York
+$5.85M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.89M
5
Wells Fargo
Wells Fargo
California
+$2.35M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$19.2M
2
Millennium Management
Millennium Management
New York
-$11.4M
3
PVI
Pura Vida Investments
New York
-$5.36M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$4.27M
5
CCM
CAAS Capital Management
New York
-$3.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$213M – – –
RG
2
Redmile Group
California
$26.2M -$210K -13,044 -0.9%
Millennium Management
3
Millennium Management
New York
$25.6M -$11.4M -704,990 -33%
DM
4
Deerfield Management
New York
$13.7M -$2.88M -178,433 -19%
NI
5
Nuance Investments
Missouri
$12.3M +$11.2M +696,850 New
PVI
6
Pura Vida Investments
New York
$9.58M -$5.36M -332,517 -38%
Vanguard Group
7
Vanguard Group
Pennsylvania
$9.11M +$4.89M +303,495 +142%
TA
8
Tamarack Advisers
California
$8.36M -$3.22M -200,000 -30%
BlackRock
9
BlackRock
New York
$7.75M +$778K +48,308 +12%
UBS AM
10
UBS AM
Illinois
$7.04M +$6.44M +399,828 New
JP Morgan Chase
11
JP Morgan Chase
New York
$6.77M +$5.85M +362,855 +1,680%
SIC
12
Salem Investment Counselors
North Carolina
$3.6M +$503K +31,225 +18%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.82M +$406K +25,172 +19%
Wells Fargo
14
Wells Fargo
California
$2.61M +$2.35M +146,094 +6,067%
State Street
15
State Street
Massachusetts
$2.33M +$1.12M +69,456 +110%
PP
16
Prospector Partners
Connecticut
$2.19M +$2M +124,355 New
Northern Trust
17
Northern Trust
Illinois
$1.66M +$11.4K +706 +0.8%
Renaissance Technologies
18
Renaissance Technologies
New York
$1.51M +$1.39M +86,000 New
Charles Schwab
19
Charles Schwab
California
$1.06M +$140K +8,662 +17%
RJA
20
Raymond James & Associates
Florida
$905K +$829K +51,432 New
AIA
21
Affinity Investment Advisors
California
$791K +$724K +44,940 New
Prudential Financial
22
Prudential Financial
New Jersey
$730K +$668K +41,450 New
SO
23
STRS Ohio
Ohio
$726K +$637K +39,500 +2,194%
CIC
24
Cornercap Investment Counsel
Georgia
$606K +$555K +34,455 New
PCM
25
Pentwater Capital Management
Florida
$598K -$338K -21,000 -38%
1
2 3

BVS Hedge Fund Activity: Q2 2021 in Review

53 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q2 2021, worth a combined $364M — up 9.1% from $334M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new BVS positions and 12 closed out — a net gain of 8 holders — while 15 added to existing stakes and 14 trimmed.

The largest buyer was Nuance Investments, opening a new position worth an estimated $11.2M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $19.2M sold.

  • 53 institutional investors held Bioventus (BVS) as of Q2 2021, up from 45 in Q1 2021.
  • Funds reported $364M of Bioventus stock for Q2 2021, up 9.1% quarter-over-quarter.
  • 20 funds opened new Bioventus positions in Q2 2021 and 12 closed out, a net change of +8 holders.
  • The largest Bioventus buyer in Q2 2021 was Nuance Investments, an estimated $11.2M added.
  • The largest Bioventus seller in Q2 2021 was Avidity Partners Management, an estimated $19.2M sold.

Based on aggregated 13F filings for Q2 2021.